Warren Pinckert II was appointed president and chiefexecutive officer of Cholestech Corp. Pinckert has been with theHayward, Calif., company since 1989, most recently asexecutive vice president of operations and chief financialofficer. Meanwhile, outgoing Cholestech president and CEOEdward Erickson has taken on a new post as president and CEOof DepoTech Corp. of La Jolla, Calif., a privately held developerof systems for sustained-release drug delivery.
Biogen Inc. of Cambridge, Mass., has appointed Michael Astruevice president and general counsel, replacing Daniel Cuoco, whoresigned. Astrue was most recently a member of Mintz LevinCohn Ferris Glovsky & Popeo, and before that served as generalcounsel to the Department of Health and Human Services underSecretary Louis Sullivan.
(c) 1997 American Health Consultants. All rights reserved.